Garcinia cambogia Ameliorates Non-Alcoholic Fatty Liver Disease by Inhibiting Oxidative Stress-Mediated Steatosis and Apoptosis through NRF2-ARE Activation. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.